Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ozempic specifically for glycaemic control in adults with type 2 diabetes, often in combination with other glucose-lowering medications or as monotherapy when metformin is not tolerated
- between 30 and 34.9: yes, if you have diastolic heart failure (also called heart failure with preserved ejection fraction), uncontrolled high blood pressure (also called hypertension), chronic kidney disease at stage 3a or higher, prediabetes, have had a heart attack, have had a stroke, or have blocked arteries in your legs or arms (peripheral artery disease)
The result is a decrease in appetite and an increase in satiety, making it easier to reduce caloric intake and promote weight loss
Retatrutide produces GI side effects at roughly 1.5 to 2 times the rate of tirzepatide
Accessibility: Available in all 50 US states
